This Cornerstone Research conference in Brussels featured expert speakers from DG Competition, private practice and academia.
This Brussels conference, hosted by Cornerstone Research, addressed the competitive impact of nascent acquisitions, especially in the technology and pharmaceutical sectors.
Speakers considered such questions as:
- When does a large, successful firm acquiring a fledgling but high-value organisation raise competition concerns?
- What evidence is there that ‘killer acquisitions’ are a real-world problem?
- Can merger control expect success in forecasting the future when examining potential entry and innovation theories of harm?
- When does economics suggest early-stage purchases will enhance or hamper innovation?